MGRX Hisse Senedi Fiyat Grafiği
MGRX Kazanmak
Mangoceuticals Inc
$0.47
-11.13%
$-0.05
Kapanışta: Aug 18, 16:00:00 GMT-4
$0.45
-3.19%
$-0.01
Sonrası Piyasa: Aug 18, 19:36:50 GMT-4
Geri
Mangoceuticals Inc (MGRX) Kazanmak
Son Finansal Sonuçlar: Q3 '25
Raporlandı: 2025-11-14
Geçmiş Kazançlar
Dönemlik
Yıllık
EPS
Gelir
Earnings FAQ
MGRX'ün son EPS'si beklentilerle karşılaştırıldığında nasıldı?
Mangoceuticals Inc MGRX'ün son çeyrekteki geliri nasıl performans gösterdi?
Mangoceuticals Inc'in gelir tahmini nedir?
Mangoceuticals Inc'in kazanç kalite puanı nedir?
Mangoceuticals Inc kazançlarını ne zaman rapor eder?
Mangoceuticals Inc'in beklenen kazançları nelerdir?
Mangoceuticals Inc kazanç beklentilerini aştı mı?
Önemli İstatistikler
Önceki Kapanış
$0.5289
Açılış fiyatı
$0.5049
Günün Aralığı
$0.455 - $0.5122
52 haftalık aralık
$0.162 - $2.75
İşlem hacmi
--
Ort.Hacim
9.1M
Dividend yield
--
EPS (TTM)
-1.61
Piyasa Değeri
$7.8M
MGRX nedir?
Mangoceuticals, Inc. engages in developing, marketing, and selling men's wellness products and services via a telemedicine platform. The company is headquartered in Dallas, Texas. The company went IPO on 2023-03-21. The company is advancing its proprietary antiviral compound MGX-0024. The firm offers pharmaceutical-based products specifically related to the treatments of erectile dysfunction (ED), hair growth, hormone replacement therapies, and weight management. The company has developed and is commercially marketing a brand of ED products under the brand name Mango; a brand of hair loss products under the brand name Grow; a brand of hormone balance and therapy products under the name Mojo, and a brand of weight loss products under the brand name Slim. Prime by MangoRx is a TRT product available by prescription. The Mango ED product includes the three ingredients: Either Sildenafil (the active ingredient in Viagra) or Tadalafil (the active ingredient in Cialis), and Oxytocin.
